文献速递神经肿瘤

老年患者经蝶窦垂体腺瘤切除术的安全性与结局

Safety and Outcome of Transsphenoidal Pituitary Adenoma Resection in Elderly Patients.
PubMed 文献 · World Neurosurg · 2018-11-14

该回顾性队列纳入205例≥60岁经蝶窦显微手术切除垂体腺瘤患者,按年龄分为60-70岁(131例)、71-80岁(65例)和>80岁(9例)三组。三组肿瘤以无功能大腺瘤为主,全切除率56.9%-80%,并发症率6.9%、9.2%、0.0%(P=0.8),无围手术期死亡。作者认为不应仅因年龄而排除手术治疗。

要点

  • ≥60岁患者经蝶窦显微手术切除垂体腺瘤,三年龄组全切除率56.9%-80%无差异。
  • 并发症率60-70岁组6.9%、71-80岁组9.2%、>80岁组0.0%(P=0.8),无围手术期死亡。
  • 作者认为不应仅因年龄排除手术,应综合评估风险与手术目标。

核心结论

  • 在该老年患者经蝶窦显微手术切除垂体腺瘤的系列中,观察到治疗具有良好的疗效和安全性。
  • 作者认为,仅仅因为年龄而排除手术治疗(包括开颅切除)是不合理的,而应综合评估患者的风险概况和手术目标。

研究设计与样本

  • 回顾性队列研究,纳入年龄≥60岁的垂体腺瘤患者205例。
  • 按年龄分为三组:60-70岁(第1组,n=131)、71-80岁(第2组,n=65)、>80岁(第3组,n=9)。

主要发现

  • 除年龄外,术前变量无差异。
  • 视力障碍为最常见表现,第1、2、3组分别为56.5%、73.8%、50%。
  • 三组肿瘤均以无功能腺瘤(P=0.97)和大腺瘤(P=0.5)为主。
  • 全切除率为56.9%-80%,组间无差异。
  • 并发症率第1组6.9%、第2组9.2%、第3组0.0%(P=0.8),无围手术期死亡。

临床怎么用

  • 作者认为,不应仅因年龄而排除手术治疗(包括开颅切除),而应综合评估患者的风险概况和手术目标。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Pituitary adenomas account for 10%-20% of intracranial brain tumors but have greater incidence in elderly patients. We assessed microsurgical treatment for pituitary adenomas in this population. METHODS: A retrospective cohort of patients ≥60 years of age was identified. Patients were divided into deciles by age for evaluation of variables affecting outcome: 60-70 (group 1), 71-80 (group 2), and >80 years (group 3). RESULTS: Two hundred five patients were identified among group 1 (n = 131), group 2 (n = 65), and group 3 (n = 9). Preoperative variables other than age did not differ. Most patients presented with visual disturbance, in 56.5%, 73.8%, and 50% in groups 1, 2, and 3, respectively. The next most common indication was headache, followed by endocrinopathy. Tumors were overwhelmingly nonfunctional (P = 0.97) and macroadenomas (P = 0.5) in all 3 groups. Gross total resection occurred in 56.9%-80% of patients, and this rate did not differ among groups. Complication rates of 6.9% in group 1, 9.2% in group 2, and 0.0% in group 3 were observed (P = 0.8). No perioperative mortality was identified. Mean length of follow-up ranged from 8.9 to 28.3 months. CONCLUSIONS: In this series of microsurgical resection of pituitary adenomas in elderly patients, good efficacy and safety of treatment were observed. Preclusion of surgical treatment, including open resection, simply because of age is not warranted and instead a comprehensive evaluation of a patient's risk profile and surgical goals should be undertaken.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Azab MA, O'Hagan M, Abou-Al-Shaar H, et al. Safety and Outcome of Transsphenoidal Pituitary Adenoma Resection in Elderly Patients. World Neurosurg. 2018. PMID: 30447462. doi:10.1016/j.wneu.2018.11.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。